Pharmacological models of amnesia: A reexamination of the effects of cholinergic muscarinic antagonist scopolamine and NMDA-receptor antagonist MK-801 on delayed nonmatching-to-position in rats

Psychobiology

Volumn 25, Issue 3, 1997, Pages 229-235

  Robinson, John K ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; SCOPOLAMINE; SODIUM CHLORIDE;

ACCURACY; AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICIPATION; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DECISION MAKING; DRUG EFFECT; MALE; MEMORY CONSOLIDATION; NONHUMAN; PERCEPTIVE DISCRIMINATION; POSITION; RAT; TASK PERFORMANCE; WORKING MEMORY;

EID: 0030725723     PISSN: 08896313     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. ABRAHAM, W. C., & MASON, S. E. (1988). Effects of the NMDA receptor/channel antagonists CPP and MK-801 on hippocampal field potentials and long-term potentiation in anesthesized rats. Brain Research, 462, 40-46.
2. BAUDRY, M., & LYNCH, G. (1988). Properties and substrates of mammalian memory systems. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 449-462). New York: Raven.
3. BLISS, T. V. P., & LOMO, T. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anesthesized rabbit following stimulation of the perforant path. Journal of Physiology, 232, 331-356.
4. BOLLER, F., & FORRETTE, F. (1989). Alzheimer's disease and THA: A review of the cholinergic theory and of preliminary results. Biomedicine & Pharmacotherapy, 43, 487-491.
5. BUSHNELL, P. J. (1990). Modeling working and reference memory in rats: Effects of scopolamine on delayed matching-to-position. Behavioral Pharmacology, 1, 419-427.
6. BUTELMAN, E. R. (1990). The effect of NMDA antagonists in the radial arm maze task with an interposed delay. Pharmacology, Biochemistry & Behavior, 35, 533-536.
7. COHEN, N. J., & EICHENBAUM, H. (1994). Memory, amnesia, and the hippocampal system. Cambridge, MA: MIT Press.
8. COTMAN, C. W., MONAGHAN, D. T., & GANONG, A. H. (1988). Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Annual Review of Neuroscience, 11, 61-80.
9. COYLE, J. T., PRICE, D. L. & DELONG, M. R. (1982). Alzheimer's disease: A disorder of cortical cholinergic innervation. Science, 219, 1184-1190.
10. DAVIES, P., & MALONEY, A. J. F. (1976). Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet, 2, 1403.
11. DUNNETT, S. B. (1985). Comparative effects of cholinergic drugs and lesions of the fimbria-fornix on delayed matching in rats. Psychopharmacology, 87, 357-363.
12. DUNNETT, S. B., WAREHAM, A. T., & TORRES, E. M. (1991). Cholinergic blockade in prefrontal cortex and hippocampus disrupts short-term memory in rats. Neuroreport, 1, 61-64.
13. FREY, P. W., & COLLIVER, J. A. (1973). Sensitivity and responsivity measures for discrimination learning. Learning & Motivation, 4, 327-342.
14. HAGAN, J. J., & MORRIS, R. G. M. (1988). The cholinergic hypothesis of memory: A review of animal experiments. In L. L. Iversen, S. D. Iversen, & S. H. Snyder (Eds.), Handbook of psychopharmacology: Psychopharmacology of the aging nervous system (Vol. 20, pp. 217-323). New York: Plenum.
15. JONES, K. W., BAUERLE, L. M., & DENOBLE, V. J. (1990). Differential effects of σ and phencyclidine receptor ligands on learning. European Journal of Pharmacology, 179, 97-102.
16. MISHKIN, M. (1982). A memory system in the monkey. Philosophical Transactions of the Royal Society of London: Series B, 209, 85-95.
17. MOLCHAN, S. E., MARTINEZ, R. A., HILL, J. A., WEINGARTNER, H. J., THOMPSON, K., VITIELLO, B., & SUNDERLAND, T. (1992). Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Brain Research Reviews, 17, 215-226.
18. MORRIS, R. G. M., ANDERSON, E., LYNCH, G. S., & BAUDRY, M. (1986). Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature, 319, 774-776.
19. MUIR, J. L., DUNNETT, S. B., ROBBINS, T. W., & EVERITT, B. J. (1992). Attentional functions of the forebrain cholinergic systems: Effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical graphs on a multiple-choice serial reaction time task. Experimental Brain Research, 89, 611-622.
20. OLTON, D. S., & WENK, G. L. (1987). Dementia: Animal models of the cognitive impairments produced by degeneration of the basal forebrain cholinergic system. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 941-953.). New York: Raven.
21. PANG, K., WILLIAMS, M. J., EGETH, H., & OLTON, D. S. (1993). Nucleus basalis magnocellularis (NBM) and attention: Effects of muscimol injections. Behavioral Neuroscience, 107, 1031-1038.
22. REISINE, T. D., YAMAMURA, H. I., BIRD, E. D., SPOKES, E., & ENNA, S. J. (1978). Pre- and post-synaptic neurochemical alterations in Alzheimer's disease. Brain Research, 159, 477-482.
23. ROBINSON, J. K., & CRAWLEY, J. N. (1993a). Intraseptal galanin potentiates scopolamine impairment of delayed nonmatching to sample. Journal of Neuroscience, 13, 5119-5125.
24. ROBINSON, J. K., & CRAWLEY, J. N. (1993b). Intraventricular galanin impairs delayed nonmatching-to-sample performance in the rat. Behavioral Neuroscience, 107, 458-467.
25. ROBINSON, J. K., & CRAWLEY, J. N. (1994). Analysis of anatomical sites at which galanin impairs delayed nonmatching to sample in rats. Behavioral Neuroscience, 108, 941-950.
26. ROBINSON, J. K., & MAO, J.-B. (in press). Differential effects on delayed nonmatching-to-position in rats of microinjections of muscarinic receptor antagonist scopolamine and NMDA receptor antagonist MK-801 into dorsal or ventral extents of the hippocampus. Brain Research.
27. 192IgG-Saporin immunotoxin and ibotenic acid lesions of the nucleus basalis and medial septum produce comparable deficits on delayed nonmatching to position in rats. Psychobiology, 24, 179-186.
28. SAKURAI, Y., & WENK, G. (1990). The interaction of acetylcholinergic and serotonergic neural systems on performance in the continuous nonmatching to sample task. Brain Research, 519, 118-121.
29. SHAPIRO, M. L., & CARAMANOS, Z. (1990). NMDA antagonist MK-801 impairs acquisition but not performance of spatial working and reference memory. Psychobiology, 18, 231-243.
30. SQUIRE, L. R. (1992). Memory and the hippocampus: A synthesis of findings from rats, monkeys, and humans. Psychological Review, 99, 195-231.
31. STAUBLI, U., THIBAULT, O., DILORENZO, M., & LYNCH, G. (1989). Antagonism of NMDA receptors impairs acquisition but not retention of olfactory memory. Behavioral Neuroscience, 103, 54-60.
32. TAN, S., KIRK, R. C., ABRAHAM, W. C., & MCNAUGHTON, N. (1989). Effects of the NMDA antagonists CPP and MK-801 on delayed conditional discrimination. Psychopharmacology, 98, 556-560.
33. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES (1985). NIH guide for the care and use of laboratory animals (Publication No. NIH 85-23. Washington, DC: U.S. Government Printing Office.
34. VOYTKO, M. L., OLTON, D. S., RICHARDSON, R. T., GORMAN, L. K., TOBIN, J. R., & PRICE, D. R. (1994). Basal forebrain lesions in monkeys disrupt attention but not learning and memory. Journal of Neuroscience, 14, 167-186.
35. WHISHAW, I. Q., & AUER, R. N. (1989). Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in the swimming pool and EEG in the rat. Psychopharmacology, 98, 500-507.
36. WILLETS, J., BALSTER, R. L., & LEANDER, J. D. (1990). The behavioral pharmacology of NMDA receptor antagonists. Trends in Pharmacological Sciences, 11, 423-428.
37. WOZNIAK, D. F., OLNEY, J. W., KETTINGER, L., III, PRICE, M., & MILLER, J. P. (1990). Behavioral effects of MK-801 in the rat. Psychopharmacology, 101, 47-56.